Passuk Medical Healthcare And Research Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.72 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -230.10%
- Ebitda -236.33%
- Net Worth -162.58%
- Total Assets 1076.80%
About Passuk Medical Healthcare And Research
Passuk Medical Healthcare And Research Private Limited (PMHARPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 March 2014 and has a history of Ten years and 11 months. Its registered office is in Udaipur, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.72 M, as per Ministry of Corporate Affairs (MCA) records.
Gopal Sukhwal, Suman Sukhwal, and Michel Daurignac serve as directors at the Company.
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100RJ2014PTC045411
- Company No.
045411
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Passuk Medical Healthcare And Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Sukhwal  | Director | 14-Mar-2014 | Current |
| Suman Sukhwal | Director | 14-Mar-2014 | Current |
Michel Daurignac  | Director | 03-Oct-2019 | Current |
Financial Performance of Passuk Medical Healthcare And Research.
Passuk Medical Healthcare And Research Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 230.1% decrease in profit. The company's net worth observed a substantial decline by a decrease of 162.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Passuk Medical Healthcare And Research?
In 2017, Passuk Medical Healthcare And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Passuk Medical Healthcare And Research?
Unlock and access historical data on people associated with Passuk Medical Healthcare And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Passuk Medical Healthcare And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Passuk Medical Healthcare And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.